{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:45:14Z","timestamp":1787010314869,"version":"build-2736575974"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1097\/rlu.0000000000000366","type":"journal-article","created":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T05:29:32Z","timestamp":1392960572000},"page":"e346-e354","source":"Crossref","is-referenced-by-count":33,"title":["Sentinel Lymph Node Mapping in Melanoma"],"prefix":"10.1097","volume":"39","author":[{"given":"Gianpiero","family":"Manca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Romanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Chiacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Tredici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mazzarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Duce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M","family":"Colletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duccio","family":"Volterrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210204","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"R2-27-20210204","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"R3-27-20210204","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma.","volume":"355","author":"Morton","year":"2006","journal-title":"N Engl J Med"},{"key":"R4-27-20210204","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10585-012-9503-3","article-title":"Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma.","volume":"29","author":"Morton","year":"2012","journal-title":"Clin Exp Metastasis"},{"key":"R5-27-20210204","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma.","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"key":"R6-27-20210204","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0039-6060(98)70121-7","article-title":"Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid.","volume":"124","author":"Gershenwald","year":"1998","journal-title":"Surgery"},{"key":"R7-27-20210204","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1200\/JCO.1998.16.6.2253","article-title":"Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.","volume":"16","author":"Gershenwald","year":"1998","journal-title":"J Clin Oncol"},{"key":"R8-27-20210204","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jso.1088","article-title":"Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: reliability of the procedure and analysis of failures after long-term follow-up.","volume":"77","author":"Jacobs","year":"2001","journal-title":"J Surg Oncol"},{"key":"R10-27-20210204","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1245\/s10434-008-0273-8","article-title":"Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI).","volume":"16","author":"Testori","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"R11-27-20210204","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1245\/s10434-006-9066-0","article-title":"Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.","volume":"13","author":"Nowecki","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R12-27-20210204","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1200\/JCO.2006.06.3198","article-title":"Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.","volume":"24","author":"Cascinelli","year":"2006","journal-title":"J Clin Oncol"},{"key":"R13-27-20210204","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1245\/s10434-009-0858-x","article-title":"Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.","volume":"17","author":"Scoggins","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R14-27-20210204","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamasurg.2013.1335","article-title":"Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result.","volume":"148","author":"Jones","year":"2013","journal-title":"JAMA Surg"},{"key":"R15-27-20210204","first-page":"147S","article-title":"Sentinel node biopsy for melanoma: where have we been and where are we going Ann Surg Oncol.","volume":"11","author":"Thompson","year":"2004","journal-title":""},{"key":"R16-27-20210204","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2967\/jnumed.108.059733","article-title":"Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECTCT.","volume":"50","author":"Leijte","year":"2009","journal-title":"J Nucl Med"},{"key":"R17-27-20210204","first-page":"103","article-title":"What is a `sentinel lymph node Eur J Surg Oncol.","volume":"26","author":"Thompson","year":"2000","journal-title":""},{"key":"R18-27-20210204","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/01.sla.0000118570.26997.a1","article-title":"Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck.","volume":"239","author":"de Wilt","year":"2004","journal-title":"Ann Surg"},{"key":"R19-27-20210204","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1245\/s10434-006-9214-6","article-title":"The reproducibility in routine clinical practice of sentinel lymph node identification by pre-operative lymphoscintigraphy in patients with cutaneous melanoma.","volume":"14","author":"Uren","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R20-27-20210204","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0b013e3181855718","article-title":"Regional recurrence after negative sentinel lymph node biopsy for melanoma.","volume":"248","author":"Carlson","year":"2008","journal-title":"Ann Surg"},{"key":"R21-27-20210204","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/jso.21439","article-title":"SPECTCT for preoperative sentinel node localization.","volume":"101","author":"Vermeeren","year":"2010","journal-title":"J Surg Oncol"},{"key":"R22-27-20210204","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1245\/s10434-009-0339-2","article-title":"The yield of SPECTCT for anatomical lymphatic mapping in patients with melanoma.","volume":"16","author":"van der Ploeg","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"R24-27-20210204","first-page":"187","article-title":"The true sentinel lymph node: in search of an operational definition of a biological phenomenon.","volume":"8","author":"Coit","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"R25-27-20210204","first-page":"12","article-title":"Will the true sentinel node please stand Ann Surg Oncol.","volume":"6","author":"Morton","year":"1999","journal-title":""},{"key":"R26-27-20210204","first-page":"192","article-title":"Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed Ann Surg Oncol.","volume":"8","author":"McMasters","year":"2001","journal-title":""},{"key":"R27-27-20210204","first-page":"234","article-title":"The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI).","volume":"47","author":"Rossi","year":"2006","journal-title":"J Nucl Med"},{"key":"R28-27-20210204","first-page":"699","article-title":"Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes.","volume":"6","author":"Gibbs","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"R29-27-20210204","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1097-0142(19900815)66:4<765::AID-CNCR2820660428>3.0.CO;2-M","article-title":"Immunohistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against S-100 subunits.","volume":"66","author":"Cho","year":"1990","journal-title":"Cancer"},{"key":"R30-27-20210204","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/ajcp\/90.1.77","article-title":"Cytodiagnosis of malignant melanoma. Immunoperoxidase staining with HMB-45 antibody as an aid to diagnosis.","volume":"90","author":"Walts","year":"1988","journal-title":"Am J Clin Pathol"},{"key":"R31-27-20210204","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archsurg.134.4.381","article-title":"Outcome of patients with melanoma and histologically negative sentinel lymph nodes.","volume":"134","author":"Gadd","year":"1999","journal-title":"Arch Surg"},{"key":"R32-27-20210204","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jama.280.16.1410","article-title":"Molecular staging of malignant melanoma: correlation with clinical outcome.","volume":"280","author":"Shivers","year":"1998","journal-title":"JAMA"},{"key":"R33-27-20210204","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1200\/JCO.1999.17.10.3238","article-title":"Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.","volume":"17","author":"Bostick","year":"1999","journal-title":"J Clin Oncol"},{"key":"R34-27-20210204","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1523-1747.2000.00925.x","article-title":"Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.","volume":"114","author":"Blaheta","year":"2000","journal-title":"J Invest Dermatol"},{"key":"R35-27-20210204","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/annonc\/mdi372","article-title":"Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome.","volume":"16","author":"Romanini","year":"2005","journal-title":"Ann Oncol"},{"key":"R36-27-20210204","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1200\/JCO.2006.09.4573","article-title":"Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis.","volume":"25","author":"Mocellin","year":"2007","journal-title":"J Clin Oncol"},{"key":"R37-27-20210204","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2967\/jnumed.108.055350","article-title":"Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.","volume":"49","author":"Manca","year":"2008","journal-title":"J Nucl Med"},{"key":"R38-27-20210204","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1200\/JCO.2005.03.2342","article-title":"Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.","volume":"24","author":"Scoggins","year":"2006","journal-title":"J Clin Oncol"},{"key":"R39-27-20210204","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1245\/ASO.2004.04.015","article-title":"2nd, Ross MI, et al. Correlation between prognostic factors and increasing age in melanoma.","volume":"11","author":"Chao","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"R40-27-20210204","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/1097-0142(20010615)91:12<2401::AID-CNCR1274>3.0.CO;2-I","article-title":"The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.","volume":"91","author":"Statius Muller","year":"2001","journal-title":"Cancer"},{"key":"R41-27-20210204","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1245\/s10434-009-0420-x","article-title":"Age-related lymphatic dysfunction in melanoma patients.","volume":"16","author":"Conway","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"R42-27-20210204","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1200\/JCO.2010.33.1884","article-title":"Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis.","volume":"29","author":"Valsecchi","year":"2011","journal-title":"J Clin Oncol"},{"key":"R43-27-20210204","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00000658-200102000-00015","article-title":"Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence.","volume":"233","author":"Clary","year":"2001","journal-title":"Ann Surg"},{"key":"R44-27-20210204","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1245\/ASO.2006.07.020","article-title":"Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma.","volume":"13","author":"Kretschmer","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R46-27-20210204","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jso.21876","article-title":"Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate.","volume":"104","author":"Balch","year":"2011","journal-title":"J Surg Oncol"},{"key":"R47-27-20210204","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/SLA.0b013e3181724f5e","article-title":"False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery, or pathology.","volume":"247","author":"Karim","year":"2008","journal-title":"Ann Surg"},{"key":"R52-27-20210204","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ncponc1205","article-title":"The rationale for sentinel-node biopsy in primary melanoma.","volume":"5","author":"Morton","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"R53-27-20210204","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1245\/s10434-007-9433-5","article-title":"Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.","volume":"14","author":"Caraco","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R54-27-20210204","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J Clin Oncol"},{"key":"R55-27-20210204","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/jnci\/djq009","article-title":"Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis.","volume":"102","author":"Mocellin","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R56-27-20210204","first-page":"CD008955","article-title":"Interferon alpha for the adjuvant treatment of cutaneous melanoma.","volume":"6","author":"Mocellin","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R57-27-20210204","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/j.seminoncol.2010.09.009","article-title":"Anti-CTLA-4 antibody adjuvant therapy in melanoma.","volume":"37","author":"Eggermont","year":"2010","journal-title":"Semin Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000000366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:08:08Z","timestamp":1620958088000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201407000-00027"}},"subtitle":["The Issue of False-Negative Findings"],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000000366","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}